HRS-4800

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameHRS-4800
Drug Alias NameHRS4800HRS-4800
ClassificationSmall molecules
Mechanisms of ActionSodium channel protein type X alpha subunit blockers
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAtridia Pty LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute PainPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A